Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Antigen Test Designed for Point-of-Care Detection

By LabMedica International staff writers
Posted on 14 Jun 2012
A novel antigen-detection test shows efficacy in rapidly identifying a variety of respiratory viruses at the point of care in a pediatric setting. More...


The automated, MultiAnalyte system, is capable of detecting from a single nasopharyngeal swab specimen eight respiratory viruses including respiratory syncytial virus (RSV); influenza A and B viruses; adenovirus; parainfluenza type 1, 2, and 3 viruses; and Human metapneumovirus.

Scientists at Turku University Hospital (Finland) evaluated the technology's efficacy in a pediatric emergency setting by testing samples from 158 children who had respiratory symptoms or fever, and whose mean age was 1.8 year. The samples were tested by MariPOC as well as by reverse-transcription polymerase chain reaction (RT-PCR).

Results with the MariPOC (ArcDia; Turku, Finland) test showed sensitivities and specificities for viral detection as follows: for the 36 children with RSV, 83% and 99%; for the 20 with influenza B, 85% and 96%; for the six with influenza A, 50% and 99%; for the 12 with adenovirus, 25% and 97%; and for the eight with Metapneumovirus, 50% and 100%.

Lauri Ivaska, MD, the lead author of the study said, "This test is based on fully automated random access immunoassay and delivers preliminary results in 20 minutes and final results in two hours. Approximately 70% of results are ready in 20 minutes. For these purposes we want to make the diagnosis reliable, easy and fast; however, most point-of-care tests for detection of respiratory viruses have limitations in diagnostic performance and clinical usability." Dr. Ivaska added, "The results indicate that whereas sensitivity for influenza and RSV was moderately good, sensitivity for adenovirus was low." The study was presented on May 10, 2012, at the European Society for Pediatric Infectious Diseases (ESPID) 30th Annual Meeting, held in Thessalonica (Greece).

Related Links:
Turku University Hospital
ArcDia



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.